Jones Hill Capital LP Quant / Systematic

Location: New York, NY

CIK: 0002102314 · Show all filings

Period: Q1 2026 (Next →)

Filing Date: May 14, 2026

Total Value: $466M (100.0% shares, 0.0% debt)

Holdings (26)

BMRN BIOMARIN PHARMACEUTICAL INC 15.4%
Value $71.65M Shares 1,268,390 Est. Cost $58.72 Unrealized 0.0%
VRTX VERTEX PHARMACEUTICALS INC 10.4%
Value $48.5M Shares 108,603 Est. Cost $467.55 Unrealized 0.0%
PCVX VAXCYTE INC 8.0%
Value $37.47M Shares 644,831 Est. Cost $52.77 Unrealized 0.0%
NUVL NUVALENT INC 6.6%
Value $30.82M Shares 300,830 Est. Cost $103.64 Unrealized 0.0%
CAPR CAPRICOR THERAPEUTICS INC 5.9%
Value $27.64M Shares 909,207 Est. Cost $24.88 Unrealized 0.0%
TERN TERNS PHARMACEUTICALS INC 5.9%
Value $27.48M Shares 521,237 Est. Cost $37.46 Unrealized 0.0%
BCAX BICARA THERAPEUTICS INC 5.4%
Value $25.06M Shares 1,260,136 Est. Cost $16.29 Unrealized 0.0%
ANIP ANI PHARMACEUTICALS INC 5.3%
Value $24.5M Shares 318,591 Est. Cost $80.37 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 5.2%
Value $24.42M Shares 1,165,557 Est. Cost $23.36 Unrealized 0.0%
ELVN ENLIVEN THERAPEUTICS INC 5.0%
Value $23.25M Shares 593,040 Est. Cost $25.60 Unrealized 0.0%
AMLX AMYLYX PHARMACEUTICALS INC 4.8%
Value $22.22M Shares 1,598,794 Est. Cost $13.99 Unrealized 0.0%
ARGX ARGENX SE 4.1%
Value $18.98M Shares 25,995 Est. Cost $730.25 Unrealized
FULC FULCRUM THERAPEUTICS INC 2.9%
Value $13.59M Shares 1,771,926 Est. Cost $10.37 Unrealized 0.0%
VIR VIR BIOTECHNOLOGY INC 2.3%
Value $10.74M Shares 1,198,213 Est. Cost $7.20 Unrealized 0.0%
NUVB NUVATION BIO INC 2.2%
Value $10.22M Shares 2,383,031 Est. Cost $6.19 Unrealized 0.0%
ORKA ORUKA THERAPEUTICS INC 1.5%
Value $6.908M Shares 140,843 Est. Cost $32.45 Unrealized 0.0%
CTNM CONTINEUM THERAPEUTICS INC 1.4%
Value $6.7M Shares 513,053 Est. Cost $13.35 Unrealized 0.0%
MANE VERADERMICS INC 1.4%
Value $6.368M Shares 100,843 Est. Cost $63.15 Unrealized
TNXP TONIX PHARMACEUTICALS HLDG C 1.3%
Value $6.217M Shares 452,116 Est. Cost $16.19 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 1.0%
Value $4.849M Shares 100,593 Est. Cost $48.20 Unrealized
TRDA ENTRADA THERAPEUTICS INC 1.0%
Value $4.72M Shares 374,010 Est. Cost $12.62 Unrealized
PHVS PHARVARIS N V 1.0%
Value $4.718M Shares 167,014 Est. Cost $26.74 Unrealized 0.0%
TRVI TREVI THERAPEUTICS INC 0.9%
Value $4.416M Shares 370,175 Est. Cost $10.94 Unrealized 0.0%
RLMD RELMADA THERAPEUTICS INC 0.5%
Value $2.386M Shares 342,752 Est. Cost $4.01 Unrealized 0.0%
SLN SILENCE THERAPEUTICS PLC 0.3%
Value $1.589M Shares 301,604 Est. Cost $5.27 Unrealized
AVBP ARRIVENT BIOPHARMA INC 0.2%
Value $1.057M Shares 45,809 Est. Cost $22.06 Unrealized 0.0%